IGY Immune Technologies & Life Sciences Inc., based in Thunder Bay, Canada, is a leader in the development and commercialization of IgY antibody-based health solutions. The company focuses on improving global health outcomes through human therapeutics, animal health, and nutraceuticals. Their proprietary MASON extraction methodology enables the production of highly purified IgY antibodies from egg yolk, used to tackle immune challenges in humans and animals. Their key product, Muno-IgY, is a nutraceutical ingredient aimed at immune and gut health support.